Insight

Dec 26, 2024, 14:23

Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma

Haematologica shared a post on X:

“Long non-coding RNA (lncRNA) have emerged as key players in the regulation of various biological processes.

A new study explores the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma.”

lncRNA

Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

Authors: Noemi Puccio, Gloria Manzotti, Elisabetta Mereu, Federica Torricelli, Domenica Ronchetti, Michela Cumerlato, Ilaria Craparotta, Laura Di Rito, Marco Bolis, Valentina Traini, Veronica Manicardi, Valentina Fragliasso, Yvan Torrente, Nicola Amodio, Niccolò Bolli, Elisa Taiana, Alessia Ciarrocchi, Roberto Piva, Antonino Neri

lncRNA

Alessia Ciarrocchi Antonino Neri biological processes cancer Domenica Ronchetti Elisa Taiana Elisabetta Mereu Federica Torricelli Gloria Manzotti Haematologica Ilaria Craparotta Laura Di Rito lncRNA Marco Bolis Michela Cumerlato multiple myeloma Niccolò Bolli Nicola Amodio Noemi Puccio OncoDaily Oncology Roberto Piva Valentina Fragliasso Valentina Traini Veronica Manicardi Yvan Torrente

Where to Study to Become ASCO President: 2025 Institutional Rankings

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book

April is Head and Neck Cancer Awareness Month